Supernus Pharmaceuticals, Inc. (SUPN) Stock

Supernus Pharmaceuticals, Inc. (SUPN) is a Healthcare stock trading at $44.38 (as of 2026-06-18), with a market capitalization of $2.68B and a trailing P/E of -90.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Supernus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for central nervous system diseases in the United States. Its products include Trokendi XR and Oxtellar XR for epilepsy and migraine, Qelbree for pediatric ADHD, and several therapies for Parkinson’s disease and related movement disorders.

Valuation — source: SEC EDGAR (first-party)
Price$44.38
Market Cap$2.68B
P/E Ratio-90.5
EV / EBITDA67.5
Price / Book2.49
Price / Sales3.45
DCF Value (model)$13.35
DCF Upside vs Price-69.9%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$718.95M
Net Margin-5.4%
Return on Equity-2.7%
Current Ratio1.96
Revenue Growth (YoY)8.6%
EPS Growth (YoY)-150.7%
FCF Growth (YoY)-73.1%
Financial Health — source: SEC EDGAR
Altman Z-Score5.03 (safe)
Valuation vs Sector & Industry
Stock P/E-90.5
Sector P/E (Healthcare)21.0
Industry P/E (Pharmaceutical Products)17.3
vs Sector-532.0%
vs Industry-624.6%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock, Inc. ($454.73M)
Institutional Holders Tracked10
Congressional Trades (recent)5
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJack A. Khattar
Employees674
CountryUS
IPO Date2012-05-01

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • IDEAYA Biosciences, Inc. (IDYA)
  • Nuvation Bio Inc. (NUVB)
  • Disc Medicine, Inc. (IRON)
  • Arcus Biosciences, Inc. (RCUS)
  • Mineralys Therapeutics, Inc. (MLYS)
  • Prestige Consumer Healthcare Inc. (PBH)
  • Catalyst Pharmaceuticals, Inc. (CPRX)
  • Beam Therapeutics Inc. (BEAM)
SUPN earnings history · SUPN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.